On the contrary, the subgroup of 25% of ccRCC patients in whom cytoplasmic presence of YAP1 in cancer cells was observed showed significantly shorter OS (median = 26.8 months) than patients without cytoplasmic YAP1 presence (median undefined) (Figure 4(b)). Here, YAP1 is linked to cancer.